MELISSA PORTER: Open Payments
NPI 1740414705 · SAVANNAH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$656 in 33 payments from 11 companies in 2025. Trend: 2023 $1,188 · 2024 $936 · 2025 $656
Food & beverage: $656
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 14 | $214 |
| Medtronic, Inc. | 3 | $115 |
| ABBVIE INC. | 4 | $81 |
| Merck Sharp & Dohme LLC | 2 | $44 |
| COLOPLAST CORP | 2 | $38 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $36 |
| Novartis Pharmaceuticals Corporation | 2 | $34 |
| Endo USA, Inc. | 1 | $28 |
| Astellas Pharma US Inc | 1 | $25 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
Products named: INTERSTIM, GEMTESA, ORGOVYX, BOTOX, Xtandi, LYNPARZA, Titan, Nubeqa.
Industry payments across GA — which companies pay providers there.
